Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
ACS medicinal chemistry letters
2025
|
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/40529091/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Broad-Spectrum Antimicrobial Efficacy of Cyclic Antimicrobial Peptide Against Multidrug-Resistant Infections. Asmamaw, Demeke Mwangi, James Michira, Brenda B Khalid, Mehwish Prateeksha Yang, Min Lu, Qiumin Yi, Wang Thuku, Rebecca Caroline Duan, Zilei Lai, Ren The increasing emergence and spread of multidrug-resistant (MDR) bacteria have intensified the search for novel antimicrobial peptides (AMPs). Here, we developed SAP 2.8 a synthetic amphipathic helical peptide, with the sequence "RCWKRWWRWWKRCWR", that demonstrates potent antibacterial activity, antibiofilm properties, and a well-characterized mechanism of action. SAP 2.8 peptide demonstrated a remarkable antibacterial effect against MDR (. ) and (MRSA) clinical isolates, with minimum inhibitory concentrations (MICs) ranging from 1.25 to 2.5 μg/mL. It also demonstrated rapid bactericidal properties, eliminating pathogens within 30 min, while maintaining low cytotoxicity toward mammalian cells. SAP 2.8 effectively inhibited bacterial biofilm formation and disrupted preformed biofilms. Mechanistic studies revealed that the peptide induces membrane rupture and permeabilization, triggering increase intracellular reactive oxygen species production, ultimately resulting in bacterial death. Notably, SAP 2.8 significantly reduced bacterial load in animal models, positioning it as a promising candidate for the treatment of Gram-positive bacterial infections.